4 ms·
too unreliable for the purposes of economic growth, tbh. based on my time in the industry, the typical biotech company lives with one foot in the grave -- and
by cryoshon 8y ago
too unreliable for the purposes of economic growth, tbh.
based on my time in the industry, the typical biotech company lives with one foot in the grave -- and we're talking about the ones which have a product on the market.
- civilitty 8y agoBased on my time in tech, every company lives with one foot in the grave unless they're a post-exit giant. Hell, I have a whole sheet in my budget dedicated to what I'm going to do when Uber goes bust or stops subsidizing my transportation. Data from the Venture Capital Association show that annualized returns from biotech investments were double that of the tech startup scene at 8% to 4% with comparable investment volume. Throw in the biotech companies that have multibillion dollar IPOs with zero revenue and you're just looking at a higher risk, higher reward version of tech.